CME Group Inc.
CME
$261.85
-$0.87-0.33%
| Weiss Ratings | CME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B+ | |||
| Rating Factors | CME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Fair | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | CME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.20 | |||
| Price History | CME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.74% | |||
| 30-Day Total Return | 5.70% | |||
| 60-Day Total Return | 12.69% | |||
| 90-Day Total Return | 18.78% | |||
| Year to Date Total Return | 13.07% | |||
| 1-Year Total Return | 27.07% | |||
| 2-Year Total Return | 55.15% | |||
| 3-Year Total Return | 23.14% | |||
| 5-Year Total Return | 87.38% | |||
| 52-Week High % Change | -1.94% | |||
| 52-Week Low % Change | 37.77% | |||
| Price | CME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $267.91 | |||
| 52-Week Low Price | $190.70 | |||
| 52-Week Low Price (Date) | Jun 18, 2024 | |||
| 52-Week High Price (Date) | Mar 19, 2025 | |||
| Valuation | CME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 94.67B | |||
| Enterprise Value | 95.49B | |||
| Price/Earnings (TTM) | 27.17 | |||
| Earnings Per Share (TTM) | 9.67 | |||
| Earnings Per Share Growth | 9.04% | |||
| Price/Earnings To Growth | 3.01 | |||
| Price/Sales (TTM) | 15.46 | |||
| Price/Book (Q) | 3.57 | |||
| Enterprise Value/Revenue (TTM) | 15.60 | |||
| Price | $261.85 | |||
| Enterprise Value/EBITDA (TTM) | 22.34 | |||
| Enterprise Value/EBIT | 24.26 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | CME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 360.05M | |||
| Dividend Yield | 4.00% | |||
| Div. Per Share (Most Recent) | $1.25 | |||
| Dividend Per Share (TTM) | $10.50 | |||
| Payout Ratio (TTM) | 101.66% | |||
| Dividend Per Share (Most Recent) | $1.25 | |||
| Company Info | CME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 312 930 1000 | |||
| Address | 20 South Wacker Drive Chicago, IL 60606 | |||
| Website | www.cmegroup.com | |||
| Country | United States | |||
| Year Founded | 1898 | |||
| Profitability | CME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 64.32% | |||
| Profit Margin | 57.60% | |||
| Management Effectiveness | CME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 1.84% | |||
| Return on Equity | 13.25% | |||
| Income Statement | CME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 5.70B | |||
| Total Revenue (TTM) | 6.12B | |||
| Revenue Per Share | $17.00 | |||
| Gross Profit (TTM) | 6.12B | |||
| EBITDA (TTM) | 4.27B | |||
| EBIT (TTM) | 3.94B | |||
| Net Income (TTM) | 3.53B | |||
| Net Income Avl. to Common (TTM) | 3.53B | |||
| Total Revenue Growth (Q YOY) | 5.98% | |||
| Earnings Growth (Q YOY) | 7.37% | |||
| EPS Diluted (TTM) | 9.67 | |||
| EPS Diluted Growth (Q YOY) | 7.19% | |||
| Balance Sheet | CME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.01B | |||
| Cash Per Share (Q) | $8.35 | |||
| Total Current Assets (Q) | 103.03B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 26.49B | |||
| Current Ratio (Q) | 1.007 | |||
| Book Value Per Share (Q) | $73.66 | |||
| Total Assets (Q) | 137.45B | |||
| Total Current Liabilities (Q) | 102.31B | |||
| Total Debt (Q) | 3.82B | |||
| Total Liabilities (Q) | 110.96B | |||
| Total Common Equity (Q) | 26.49B | |||
| Cash Flow | CME - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -82.60M | |||
| Cash from Financing (TTM) | 5.08B | |||
| Net Change in Cash (TTM) | 8.68B | |||
| Levered Free Cash Flow (TTM) | 2.64B | |||
| Cash from Operations (TTM) | 3.69B | |||
